基于网络药理学探讨黄芩素对猪丁型冠状病毒感染的潜在作用机制

本研究旨在探讨黄芩素抗猪丁型冠状病毒（porcine deltacoronavirus,PDCoV）感染的作用机制。通过Pharmmapper、Pubchem、STITCH、TCMSP和Swiss Targer Prediction数据库获得黄芩素的作用靶点。根据前期蛋白组学结果获得PDCoV感染的相关靶点,获取黄芩素与PDCoV感染的共同靶点,并利用STRING数据库和Cytoscape 3.8.2软件构建“药物-疾病-靶点”网络和靶蛋白相互作用网络,利用CytoNCA插件进行网络拓扑分析和核心网络构建,使用Metascape数据库对核心网络基因进行GO和KEGG分析。通过细胞试验对富集得到的信号通路下游基因表达水平进行检测。通过筛选,共获得黄芩素的潜在靶基因268个,黄芩素-PDCoV的共同靶点75个,GO富集结果表明黄芩素主要参与细胞周期、细胞膜筏形成、线粒体膜形成、纺锤体形成和MAPK信号级联传导过程;KEGG富集筛选得到277条信号通路（P<0.01）,主要涉及PI3K-Akt信号通路、Ras信号通路和MAPK信号通路等。细胞试验结果表明,与正常细胞对照组相对,病毒感染后PI3K、AKT、NF-κB mRNA表达显著升高;与病毒感染组相比,黄芩素处理组PI3K、AKT、NF-κB mRNA的表达显著降低（P<0.05）。黄芩素对PDCoV感染的作用具有多靶点、多通路的特点,可能是通过作用于AKT1、HSP90AA1、SRC、EGFR、CASP3、MAPK、STAT3等核心基因调控PI3K-Akt、Ras和MAPK信号通路、细胞凋亡、病毒感染等通路发挥作用,可以作为抗PDCoV感染的潜在治疗药物进一步研究。     

猪流行性腹泻病毒S2基因B细胞表位的筛选及其单克隆抗体的制备与鉴定

目的 应用生物学软件与单克隆抗体技术相结合的方法鉴定PEDV S2基因B细胞表位肽。方法 利用CLC Sequence viewer 6.8软件及在线数据库IEDB筛选出PEDV S2基因B细胞表位,并人工合成表位肽。将表位肽与钥孔血蓝蛋白（KLH）耦联后作为抗原,免疫雌性BALB/c小鼠,通过ELISA法筛选出抗体效价较高的小鼠进行1次加强免疫,3 d后取脾脏制备脾细胞悬液进行细胞融合。经HAT选择培养基培养筛选有效杂交瘤细胞,采用ELISA法筛选阳性克隆继续进行扩大培养。将部分阳性杂交瘤细胞进行小鼠腹腔注射,并收集腹水。通过ELISA方法分别检测小鼠腹水和单克隆细胞株培养上清液抗体效价,确定最高效价作为后备细胞株。结果 筛选出B细胞表位肽序列为:MQYVYTPTYYML;免疫多肽抗原后融合前血清抗体效价达到1:2 000;BALB/c小鼠腹水及单克隆细胞株培养物上清液ELISA检测结果显示抗体效价达到1:4 000。结论 筛选出了PEDV S2基因B细胞表位,为PEDV表位肽疫苗载体构建研究提供参考。     

猪繁殖与呼吸综合征疫苗的研究进展

猪繁殖与呼吸综合征(PRRS)是由猪繁殖与呼吸综合征病毒(PRRSV)引起的严重危害世界养猪业的一种传染病,该病可造成猪的繁殖障碍、呼吸系统病症与生长受阻。本文着眼于PRRSV疫苗的免疫原性、保护效力和安全性,涉及市场上现有的商品化疫苗与已报道的处于试验阶段的相关疫苗研究成果,以期为PRRSV的防控与疫苗研发提供有益的参考。     

硒蛋白X基因克隆、定点突变、原核表达及多克隆抗体制备

本试验旨在克隆鉴定猪硒蛋白X(Sel X)基因,将其定点突变后进行原核表达,获得重组蛋白,并制备猪Sel X多克隆抗体,为以猪为模型Sel X功能研究奠定基础。利用c DNA末端快速克隆(3'-RACE)技术从猪肝脏总RNA扩增出含开放阅读框(ORF)至poly(A)共1 215 bp的Sel X基因c DNA片段,其348 bp的ORF编码区和对应的氨基酸残基与人相应序列分别有88%和91%序列同源性,猪Sel X基因提交NCBI Gen Bank数据库,序列号为EF113597。ORF编码氨基酸残基中硒代半胱氨酸(Sec)位于C-端第95个残基,其编码密码子TGA经定点突变为半胱氨酸(Cys)的TGT后,将其插入载体p ET30,转入大肠杆菌BL21(DE3)中,在0.5 mmol/L异丙基硫代-β-D-半乳糖苷(IPTG)诱导2 h获得融合表达产物,经His-tag亲和层析后,获得分子质量为18.0 ku的纯化蛋白。将纯化获得的Sel X基因突变体融合蛋白(Sel Xm)免疫兔子,得到效价高达1∶20 000的多克隆抗体,免疫印迹(Western-blot)结果显示该抗体能特异性识别纯化的Sel Xm和猪肝脏中相应Sel X。本试验成功克隆并鉴定了猪Sel X基因,并制备了其多克隆抗体。     

Gene cloning of porcine adiponectin gene from adipose tissue and construction of its eukaryotic expression vector

To clone adiponectin (ADPN) gene from Shaziling porcine adipocyte and construct its eukaryotic expression vector, total RNA was extracted from subcutaneous fatty tissue. One pair of specific primers was designed by Primer 5.0 software according to the sequence of ADPN gene of porcine available in GenBank. The ADPN gene was amplified by PCR from cDNA and cloned into pMD18‐T vector to construct recombinant clonal vector pMD‐ADPN, sequenced and analysed. A recombinant expression plasmid pPICZaA‐ADPN was constructed by subcloning the cloned ADPN gene into the linearized pPICZaA vector. Then, the plasmid pPICZaA‐ADPN was expressed in Pichia pastoris (GS115) by electrotransformation. Western blot and Bradford analysis were used to determine the target protein induced by methanol. Results showed that the genome size of ADPN was 732 bp and encoded 244 amino acid, the nucleotide sequence of ADPN shared 100% identity with that of porcine available in GenBank. Western blot and Bradford analysis showed that the recombinant ADPN was expressed in GS115 correctly and has certain immune activity. The expression level of ADPN was 28.5 μg/ml. In conclusion, the recombinant ADPN could express in eukaryotic expression vector pPICZaA‐ADPN constructed in this study effectively.     

猪α-干扰素表达系统及其应用的研究进展

就猪α-干扰素的分子特征、生物学特性、表达系统和猪基因工程α-干扰素的应用进行综述,以期为猪α-干扰素在广谱抗病毒活性、抗肿瘤以及免疫调节的临床应用提供参考。     

国内商品化猪圆环病毒疫苗的现状及展望

截至2013年12月份,已有16家企业6种不同的猪圆环病毒2型灭活疫苗获得了农业部的注册,其中有批签发的企业14家。整理了猪圆环病毒疫苗在我国的商品化情况,分类总结了该类疫苗工艺核心等基本情况,同时分析了猪圆环疫苗的优缺点,并对猪圆环病毒疫苗的发展前景进行了展望。     

ULTRASONOGRAPHIC CHARACTERISTICS OF LIPIDURIA IN CLINICALLY NORMAL CATS

Echoes are frequently seen in the urinary bladder of cats during abdominal ultrasound. These have been attributed to hematuria, pyuria, crystalluria, and lipid. However, sonographic findings have not been previously correlated with urinalysis. We prospectively evaluated 40 clinically normal cats via ultrasound, serum chemistry, and urinalysis. Thin layer chromatography was performed on the urine to determine the amount (mg) of lipid subfractions including diacylglycerol, triglyceride, phospholipid, free fatty acid, cholesterol, and cholesterol ester. Ninety percent (36/40) of the cats in our population had sonographic echoes suspended in the urinary bladder, with most having a subjective score of mild echoes (n = 20). None of the sonographic echoes were gravity dependent or caused distal acoustic shadowing, reverberation, or twinkle artifact. Of the cats with sonographic echoes in the urine, 66% (24/36) had no significant findings on urinalysis other than the presence of lipid. The total amount of subjective sonographic echoes was not significantly related to the total amount of fat measured on thin layer chromatography or the number of lipid droplets seen on urinalysis. An increased amount of urine diacylglycerol was significantly associated with clumping of echoes (P = 0.02) and the amount of lipid droplets seen on urinalysis (P = 0.04). An association between increased amounts of urine diacylglycerol and the amount of echoes seen on ultrasound approached significance (P = 0.05). Findings from this study support previously published theories that sonographic echoes within the urinary bladder of clinically normal cats may be due to urine lipid.     

Enhancing mucosal immunity in mice by recombinant adenovirus expressing major epitopes of porcine circovirus-2 capsid protein delivered with cytosine-phosphate-guanosine oligodeoxynucleotides

A recombinant replication-defective adenovirus expressing the major epitopes of porcine circovirus-2 (PCV-2) capsid protein (rAd/Cap/518) was previously constructed and shown to induce mucosal immunity in mice following intranasal delivery. In the present study, immune responses induced by intranasal immunization with a combination of rAd/Cap/518 and cytosine-phosphate-guanosine oligodeoxynucleotides (CpG ODN) were evaluated in mice. The levels of PCV-2-specific IgG in serum and IgA in saliva, lung, and intestinal fluids were significantly higher in the group immunized with rAd/Cap/518 and CpG ODN than animals immunized with rAd/Cap/518 alone. The frequencies of IL-2-secreting CD4⁺ T cells and IFN-γ-producing CD8⁺ T cells were significantly higher in the combined immunization group than mice immunized with rAd/Cap/518 alone. The frequencies of CD3⁺, CD3⁺CD4⁺CD8^-, and CD3⁺CD4^-CD8⁺ T cells in the combined immunization group were similar to that treated with CpG ODN alone, but significantly higher than mice that did not receive CpG ODN. PCV-2 load after challenge in the combined immunization group was significantly lower than that in the phosphate-buffered saline placebo group and approximately 7-fold lower in the group treated with CpG ODN alone. These results indicate that rAd/Cap/518 combined with CpG ODN can enhance systemic and local mucosal immunity in mice, and represent a promising synergetic mucosal vaccine against PCV-2.